Who owns AstraZeneca PLC, from the filings themselves: stakes over 5% (Schedule 13D/G), the institutional managers reporting the stock each quarter (13F), and the funds holding it (N-PORT).
Investors crossing 5% ownership must disclose it. Schedule 13G filers certify the stake is passive; Schedule 13D is the general form for everyone else — founders, strategic holders, and activists alike. Each entry is the holder's most recent disclosure. Coverage begins with SEC's structured filings from December 18, 2024; a holder appears once they file or amend after that date.
Vanguard Capital Management: 5.0% · 77,965,099 shares
BlackRock, Inc.: 7.6% · 117,761,076 shares
Every institutional manager whose latest 13F reports this stock, largest position first. "% of their portfolio" is the weight inside that manager's own book — how much conviction the position represents; "% of company" is how much of AstraZeneca PLC they hold.
| Investor | Position value | Shares | % of their portfolio | % of company | As of |
|---|---|---|---|---|---|
| Evelyn Partners Group Ltd | $41.5B | 2,237,205 | 88.60% | — | June 30, 2026 |
| INVESTOR AB | $9.78B | 51,587,810 | 67.92% | — | June 30, 2026 |
1,601 more institutional holders behind a free account
See every manager reporting AstraZeneca PLC, how much of the company they hold, and how big the position is inside their own portfolio.
Sign up freeFunds disclosing this stock in their monthly N-PORT portfolio, with the position's share of the fund's net assets.
| Fund | Position value | % of net assets | % of company | As of |
|---|---|---|---|---|
| Nuveen International Equity Index Fund | $461M | 1.33% | — | April 30, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | $451M | 0.31% | — | June 30, 2026 |
148 more funds behind a free account
See every fund holding AstraZeneca PLC and what share of its net assets the position represents.
Sign up freeLoading...
